US 10709692
Isoxazolidine derived inhibitors of receptor interacting protein kinase 1 (RIPK1)
granted A61KA61K2121/00A61K31/422
Quick answer
US patent 10709692 (Isoxazolidine derived inhibitors of receptor interacting protein kinase 1 (RIPK1)) held by DENALI THERAPEUTICS INC. expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DENALI THERAPEUTICS INC.
- Grant date
- Tue Jul 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2121/00, A61K31/422, A61K31/4439, A61P